Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

This year’s winter flu season appears to be the most serious in 15 years, with cases ticking higher than at the peak of the ...

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

Milestone Pharmaceuticals (MIST) announced that it has received Notice of Allowance from the United States Patent and Trademark Office, or ...

Researchers at Texas A&M University College of Medicine have developed a new therapy that may slow the progression of ...

Tears were shed Friday at the Hawaii Island Fentanyl Task Force sign-waving rally as former addicts, victims, anti-drug ...

A Massachusetts man became the first person to try intranasal foralumab under an expanded access program for people with ...

Letters to the editors for the November 2024 issue of Scientific American ...

A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...

Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.

The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.

This nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and ...